Progressive loss of cholinergic neurons is observed in Alzheimer's disease (AD) patients with severe memory loss and impairment of cognitive function [2], and AChE inhibitors have been used for such patients to protect against the reduction of acetylcholine in the synapses and to enhance cholinergic activity in the affected regions of the brain [3]. This evidence concerns the gene ACHE and Alzheimer disease.